Table 2 IHC detection of HFGs by anti-HFG mAb in paired NAT and tumor tissues of 29 patients with CRC
From: Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer
Staining of tumor tissue versus NAT (n = 29) | Tumor tissue | ||
|---|---|---|---|
Positive (%) | Negative | ||
NAT | Positive | 9 (31) | 0 |
Negative | 17 (59) | 3 (10%) | |